For stretched public health budgets, high-tech treatments are hard to afford but some pre-emptive measures can prove good value

Wellcome’s John-Arne Røttingen says divisions risk harming action on pandemic responses and ‘superbugs’

Danish group beats expectations with first-quarter sales up 24% and raises annual forecast on high demand

The UK is a world leader in finding new treatments to tackle diseases

Drugmaker could fast track subsidiary’s bankruptcy process if 75% of claimants vote in favour of new plan

Quarterly results beat expectations and signal strong start for pharma group